drugset / Trial / NCT00276510

A Study of EGb 761® (Tanakan®) in Dementia of Alzheimer Type Onset in Patients Suffering From Memory Complaints

NCT00276510

Phase 4 Completed 2878 enrolled Ipsen
RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this study is to determine whether Tanakan® is effective at slowing the progression from memory complaint to dementia of Alzheimer's type.

Timeline

Start
2002-02
Primary completion
2009-11
Completion
2009-11

Drugs

EvaluationDrugModalityDoseRoute
Subject Ginkgo Biloba Extract Traditional medicine (herbal / TCM) 120 mg Oral